Division News

Grand Rounds 4/18/14: Rethinking Type 2 Diabetes

Medicine Grand Rounds on Fri., April 18 at 8 a.m. in Duke Hospital room 2002 will feature Francis A. Neelon, MD, associate professor of medicine (Endocrinology, Metabolism and Nutrition), Emeritus, and Medical Director, Rice House Healthcare Program. Dr.

Batch receives KL2 Scholar Award

CTSA-badgeBryan Batch, MD, assistant professor of medicine (Endocrinology, Metabolism and Nutrition), was recently awarded one of three KL2 Scholar Award from Duke Translational Medicine Institute. The award offers funding, formal coursework, mentoring and research assistance and is part of the Duke CTSA. Dr.

David D'Alessio chosen to be chief of Division of Endocrinology

Mary Klotman, MD, chair of the Department of Medicine, announced today that David D’Alessio, MD, has agreed to be the Chief of the Division of Endocrinology, Metabolism and Nutrition, effective November 26, 2013. (He will begin full time in April 2014.) Currently, Dr. D'Alessio is Professor of Medicine and the Albert Vontz Chair for Diabetes Research at the University of Cincinnati, where he also serves as Director of the Division of Endocrinology.

Grand Rounds 8/9/13: Diabetes drug safety

Medicine Grand Rounds on Fri., Aug. 9 at 8 a.m. in Duke Hospital room 2002 will feature Jennifer Green, MD, associate professor of medicine (Endocrinology, Metabolism and Nutrition) and chief of the Endocrine Section at the Durham VA Medical Center, and a case presentation by Jennifer Rymer, MD, MBA,  senior assistant resident. Dr.

Slow-release 'jelly' is novel drug deliverer

Mark N. Feinglos, MD, CM, professor of medicine (Endocrinology, Metabolism and Nutrition) and associate professor of Pathology and Psychiatry and Behavioral Sciences, is part of a team of Duke researchers who have developed a new method to overcome major hurdles facing a promising new class of peptide drugs to treat diseases such as diabetes and cancer.